Fineline Cube

Follow:
14475 Articles
CompanyDrug

Jiangsu Hengrui’s Ivarmacitinib for Adult Alopecia Areata Accepted for Review by China’s CDE

Policy / RegulatoryR&D

US Allows Science and Technology Agreement with China to Expire, Pointing to Deepening R&D Competition

Company

Novartis Builds Two Radioligand Therapy Facilities in U.S. to Expand Cancer Treatment Capabilities

Deals

Jiangsu Suzhou Launches $843 Million Biomedicine Fund to Boost Pharma and Medical Device Innovation

CompanyDeals

Sage Group Expands into China’s Healthcare Market with Cenponts Healthcare Partnership

CompanyDrug

Hanx Biopharmaceuticals Receives NMPA Approval for HX009 Combination Therapy Phase II Trial

CompanyDeals

E-commerce and Physical Stores to Stock Hanmi’s OTC Drugs Following Shanghai Pharma Deal

Company

Aspen Pharmacare’s 2024 Fiscal Report Shows Mixed Results Amid China’s VBP Impact

CompanyDrug

European Commission Approves Merck’s Keytruda-Padcev Combo for First-Line Urothelial Carcinoma Treatment

CompanyDrug

Manufacturing Challenges for Novo Nordisk’s Ozempic Impact Diabetes and Obesity Treatments in Europe

CompanyDrug

Skyline Therapeutics’ Gene Therapy Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment

CompanyDeals

CGeneTech Secures RMB 100 Million in Series C Financing to Advance Drug Commercialization and Clinical Pipeline